Skip to main content
Eric Singhi, MD, Oncology, Houston, TX

EricKumarSinghiMD

Oncology Houston, TX

Thoracic/Head & Neck Medical Oncologist, Assistant Professor at MD Anderson Cancer Center

Dr. Singhi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Singhi's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161
    Fax+1 713-792-3708

Summary

  • Dr. Eric K. Singhi is a thoracic/head and neck medical oncologist and Assistant Professor at the University of Texas MD Anderson Cancer Center. He received his medical degree from the Medical University of South Carolina College of Medicine and completed his Internship and Residency training in Internal Medicine at Vanderbilt University. He subsequently completed his hematology and medical oncology fellowship training at the University of Texas MD Anderson Cancer Center, serving as Chief Education Fellow. He also speaks multiple languages, including Hindi and Spanish. He specializes in General Internal Medicine and Hematology/Oncology. He has an interest in thoracic medical oncology, patient-reported outcomes, patient education, and community outreach.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 2017 - 2022
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterInternship, Internal Medicine, 2016 - 2017
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 2016
  • Duke University
    Duke UniversityBS, Neuroscience, Spanish, Genome Sciences, Magna Cum Laude, Phi Beta Kappa, Graduation with Distinction, 2008 - 2012

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2027
  • GA State Medical License
    GA State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • MS State Medical License
    MS State Medical License 2023 - 2025
  • OK State Medical License
    OK State Medical License 2023 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Alpha Omega Alpha
  • Gold Humanism Honor Society

Publications & Presentations

PubMed

Journal Articles

  • “Triple-triple” hit lymphoma  
    Mushtaq S, Singhi EK, Stuart R, Case Reports in Internal Medicine, 10/2015
  • Addressing tobacco use at NCI designated cancer centers: Online resources available for patients.  
    Eric K. Singhi, Alix W. Pommerenke, Sarah Mushtaq, Kenneth Michael Cummings, James Roger Marshall, Anthony Alberg, and Graham Walter Warren, Journal of Clinical Oncology, 2015

Authored Content

  • Simmering Below the Surface: Sweet's Syndrome with Multiple Myeloma,,✰✰✰,✰✰✰✰☆✰✰✰✰May 2018
  • Simmering Below the Surface: Sweet's Syndrome with Multiple Myeloma,,✰✰✰,✰✰✰✰☆✰✰✰✰May 2018

Press Mentions

  • IASLC 2024 World Conference on Lung Cancer: Dr. Singhi Discusses Highly Anticipated Sessions
    IASLC 2024 World Conference on Lung Cancer: Dr. Singhi Discusses Highly Anticipated SessionsAugust 27th, 2024
  • FDA Approvals Create “Difficult Decisions” in Early-Stage Resectable NSCLC
    FDA Approvals Create “Difficult Decisions” in Early-Stage Resectable NSCLCAugust 26th, 2024
  • Are Subcutaneous Drugs the Key to Cancer Care’s Future?
    Are Subcutaneous Drugs the Key to Cancer Care’s Future?August 20th, 2024
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi, Spanish